Monopar Therapeutics Inc's total assets for Q2 2024 were $7.18M, a decrease of -19.44% from the previous quarter. MNPR total liabilities were $1.09M for the fiscal quarter, a -24.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.